Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir for Immune Thrombocytopenia
NCT03520049Phase 3Unknown
- Sponsor
- Unity Health Toronto
- Start
- Nov 2016
- Primary completion
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oseltamivir in immune thrombocytopenia (ITP), sponsored by Unity Health Toronto. Status: unknown.
02
Drugs
oseltamivir
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT03520049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03520049.